SlideShare ist ein Scribd-Unternehmen logo
1 von 29
U N I V E R S I T Ä T S M E D I Z I N  B E R L I N Prof. Dr. Detlev Ganten, February 2, 2011 [email_address] BioMedical  technologies at Skolkovo: Opportunities and Challenges.
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
Science for Higher Education 19. November 2010 R&D expenditure in billions of Euro (2007 data) Source: BUFI 2010 EN
Excellence Initiative ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Science for Higher Education 19. November 2010
Awards per scientific discipline per  funding line 1st round Science for Higher Education 19. November 2010 Source: DFG 2010
[object Object],[object Object],What can we know? What shall we do? What can we hope for?
 
300 Mio 300 Mio 100 Mio about  2 billion people are treated according to scientific standards. about  5 billion people are badly treated or not taken care of at all.  100 Mio
Evolutionary Medicine: our biologigal history goes back to the origins  of life and works on old patents
Our civilisation is new, changes are fast: ,[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
  1 Compound Annual Growth Rate (CAGR) Inpatient care  SOURCE: OECD 4.0 17.5 2.2 3.2 6.1 10.9 3.2 25.3 3.8 3.0 4.4 2 8 8 10 10 13 14 34 51 80 Ancillary services Day care Primary prevention Investments in medical facilities Pharmaceutical goods Outpatient care Therapeutic appliances Home health care Health administra-tion and insurance Total health  care expenditure Health care spend  EUR billions, 2006 Annual growth rate*  Percent, 1970 - 2006 In Germany, patient care and pharmaceuticals are  among the biggest health care expenditures Expenditures for primary care have been growing slower than all other expenditures Total = 230 bn.
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Genotype Personalised  Medizine Clinical Systems Biology Bioinformatics Sequencing, Analysis Phenotype Health – Disease  Cardiovascular - Neuro - Cancer   micro RNA, RNAi Drugs Biologicals aaa DNA (Genome: 20.000 Genes) RNA Proteins (Proteome) Metabolites (Metabolome) Cellular Biology Organs ( Microbiome)
eMonitoring -Networking Sensors Analysis ? TeleMedicine – IT -  for your personal Health Blut- zucker Blutdruck EKG Ther- mome- ter
Telemedical Center of the Charit é   –  Global Service Med. Service LH nein Cardiology Traumatology Internal Medicine Toxicol. & others … Anesthesia/Ints. Care Ships,  Yachts, Oil Plat. Home Care Private Flights Telemedical Call Center Emergency Unit Charité Foreign Hospitals:  Moscow, Shanghai Ger. Foreign Office, Ger. Embassies Intern. Companies
Architecture of the PfH- communication system Winkler S, Koehler F. Int J Cardiol 2010; in review. Patient Medical Partners TMC-physician Ambulance Hospital phys. GP Cardiologist Electronic Patient File Transmission paths for health data Transmission Transmission via Bluetooth Blood pressure ECG + SpO 2 Aktivity Weight Transmission via mobile  phone Notification Treatmemt Control Communication paths in normal cases Communication paths in case of emergency Home emergency call IMMEDIATE  REACTION Notification
Telemedicine helps you to feel safe, even when you are on a  lonely trip to Siberia All the best to you and your family.
Berlin-Buch Adlershof BOSCH HU & FU GHC Global Health Care
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
300 Mio 300 Mio 100 Mio about  2 billion people are treated according to scientific standards. about  5 billion people are badly treated or not taken care of at all.  100 Mio
 
 
The  G 8 GROUP - G 20
1 Dec Nov Oct Sep Aug Jul Jun May Apr Mar Feb Jan World Health Summit serves as an annual conference of the M8
U N I V E R S I T Ä T S M E D I Z I N  B E R L I N Prof. Dr. Detlev Ganten , February 2, 2011 [email_address] BioMedical  technologies at Skolkovo: Opportunities and Challenges. THANK  YOU !

Weitere ähnliche Inhalte

Ähnlich wie Detlev Ganten Skolkovo biomedical technologies opportunities and challenges

EPAD 2017 - Jan Willem Van de Loo
EPAD 2017 - Jan Willem Van de LooEPAD 2017 - Jan Willem Van de Loo
EPAD 2017 - Jan Willem Van de LooMarc van Gurp
 
Major Neglected Tropical Diseases (NTD)
Major Neglected Tropical Diseases (NTD)Major Neglected Tropical Diseases (NTD)
Major Neglected Tropical Diseases (NTD)Updesh Yadav
 
Health Valley Event Presentatie Rob ten Hoedt
Health Valley Event Presentatie Rob ten HoedtHealth Valley Event Presentatie Rob ten Hoedt
Health Valley Event Presentatie Rob ten HoedtHealth Valley
 
Prof Arzu KANIK World Medical Journal MedicReS Good Biostatistical Practice (...
Prof Arzu KANIK World Medical Journal MedicReS Good Biostatistical Practice (...Prof Arzu KANIK World Medical Journal MedicReS Good Biostatistical Practice (...
Prof Arzu KANIK World Medical Journal MedicReS Good Biostatistical Practice (...MedicReS
 
Beyond Scaling Up: Building the evidence base
Beyond Scaling Up: Building the evidence baseBeyond Scaling Up: Building the evidence base
Beyond Scaling Up: Building the evidence baseIDS
 
Mark Lawler - European Cancer Concord and Queens University Belfast - 8th Eur...
Mark Lawler - European Cancer Concord and Queens University Belfast - 8th Eur...Mark Lawler - European Cancer Concord and Queens University Belfast - 8th Eur...
Mark Lawler - European Cancer Concord and Queens University Belfast - 8th Eur...Cittadinanzattiva onlus
 
Opening Session 11th July 2010: IUHPE 20th Health Promotion Conference
Opening Session 11th July 2010: IUHPE 20th Health Promotion Conference Opening Session 11th July 2010: IUHPE 20th Health Promotion Conference
Opening Session 11th July 2010: IUHPE 20th Health Promotion Conference IUHPE2010
 
Opening session presentation
Opening session presentationOpening session presentation
Opening session presentationIUHPE2010
 
Pre0001 eder joachim
Pre0001 eder joachimPre0001 eder joachim
Pre0001 eder joachimngasuma
 
EuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
EuroBioForum 2013 - Day 1 | Emmanuelle BenzimraEuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
EuroBioForum 2013 - Day 1 | Emmanuelle BenzimraEuroBioForum
 
Global health 110617
Global health 110617Global health 110617
Global health 110617bdietrich
 
MSD AIA Forum - 2009 Brochure
MSD AIA Forum - 2009 BrochureMSD AIA Forum - 2009 Brochure
MSD AIA Forum - 2009 BrochureBoris Azaïs
 
Dr. Manuel Trajtenberg
Dr. Manuel TrajtenbergDr. Manuel Trajtenberg
Dr. Manuel Trajtenbergichil
 
How to improve the health of the Polish population. Health 2020 – the Europea...
How to improve the health of the Polish population. Health 2020 – the Europea...How to improve the health of the Polish population. Health 2020 – the Europea...
How to improve the health of the Polish population. Health 2020 – the Europea...WHO Regional Office for Europe
 
Presentation for NGO " The Association for the Health of Society"
Presentation for NGO " The Association for the Health of Society"Presentation for NGO " The Association for the Health of Society"
Presentation for NGO " The Association for the Health of Society"Sofia glinyana
 
Health 2020: A New European Policy Framework for Health and Well-Being
Health 2020: A New European Policy Framework for Health and Well-BeingHealth 2020: A New European Policy Framework for Health and Well-Being
Health 2020: A New European Policy Framework for Health and Well-BeingWHO Regional Office for Europe
 
Healthcare Trends 2020: How the UK is Shaping the Medicine of the Future
Healthcare Trends 2020: How the UK is Shaping the Medicine of the FutureHealthcare Trends 2020: How the UK is Shaping the Medicine of the Future
Healthcare Trends 2020: How the UK is Shaping the Medicine of the FutureAlex Artyomenko
 

Ähnlich wie Detlev Ganten Skolkovo biomedical technologies opportunities and challenges (20)

EPAD 2017 - Jan Willem Van de Loo
EPAD 2017 - Jan Willem Van de LooEPAD 2017 - Jan Willem Van de Loo
EPAD 2017 - Jan Willem Van de Loo
 
Major Neglected Tropical Diseases (NTD)
Major Neglected Tropical Diseases (NTD)Major Neglected Tropical Diseases (NTD)
Major Neglected Tropical Diseases (NTD)
 
Health Valley Event Presentatie Rob ten Hoedt
Health Valley Event Presentatie Rob ten HoedtHealth Valley Event Presentatie Rob ten Hoedt
Health Valley Event Presentatie Rob ten Hoedt
 
Prof Arzu KANIK World Medical Journal MedicReS Good Biostatistical Practice (...
Prof Arzu KANIK World Medical Journal MedicReS Good Biostatistical Practice (...Prof Arzu KANIK World Medical Journal MedicReS Good Biostatistical Practice (...
Prof Arzu KANIK World Medical Journal MedicReS Good Biostatistical Practice (...
 
Beyond Scaling Up: Building the evidence base
Beyond Scaling Up: Building the evidence baseBeyond Scaling Up: Building the evidence base
Beyond Scaling Up: Building the evidence base
 
Biomedical engineering
Biomedical engineering Biomedical engineering
Biomedical engineering
 
Mark Lawler - European Cancer Concord and Queens University Belfast - 8th Eur...
Mark Lawler - European Cancer Concord and Queens University Belfast - 8th Eur...Mark Lawler - European Cancer Concord and Queens University Belfast - 8th Eur...
Mark Lawler - European Cancer Concord and Queens University Belfast - 8th Eur...
 
Opening Session 11th July 2010: IUHPE 20th Health Promotion Conference
Opening Session 11th July 2010: IUHPE 20th Health Promotion Conference Opening Session 11th July 2010: IUHPE 20th Health Promotion Conference
Opening Session 11th July 2010: IUHPE 20th Health Promotion Conference
 
Opening session presentation
Opening session presentationOpening session presentation
Opening session presentation
 
Pre0001 eder joachim
Pre0001 eder joachimPre0001 eder joachim
Pre0001 eder joachim
 
EuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
EuroBioForum 2013 - Day 1 | Emmanuelle BenzimraEuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
EuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
 
Cancer 2014: Why do we need a focus on value?
Cancer 2014: Why do we need a focus on value?Cancer 2014: Why do we need a focus on value?
Cancer 2014: Why do we need a focus on value?
 
Global health 110617
Global health 110617Global health 110617
Global health 110617
 
Toshiba's VISIONS Magazine - issue 25
Toshiba's VISIONS Magazine - issue 25Toshiba's VISIONS Magazine - issue 25
Toshiba's VISIONS Magazine - issue 25
 
MSD AIA Forum - 2009 Brochure
MSD AIA Forum - 2009 BrochureMSD AIA Forum - 2009 Brochure
MSD AIA Forum - 2009 Brochure
 
Dr. Manuel Trajtenberg
Dr. Manuel TrajtenbergDr. Manuel Trajtenberg
Dr. Manuel Trajtenberg
 
How to improve the health of the Polish population. Health 2020 – the Europea...
How to improve the health of the Polish population. Health 2020 – the Europea...How to improve the health of the Polish population. Health 2020 – the Europea...
How to improve the health of the Polish population. Health 2020 – the Europea...
 
Presentation for NGO " The Association for the Health of Society"
Presentation for NGO " The Association for the Health of Society"Presentation for NGO " The Association for the Health of Society"
Presentation for NGO " The Association for the Health of Society"
 
Health 2020: A New European Policy Framework for Health and Well-Being
Health 2020: A New European Policy Framework for Health and Well-BeingHealth 2020: A New European Policy Framework for Health and Well-Being
Health 2020: A New European Policy Framework for Health and Well-Being
 
Healthcare Trends 2020: How the UK is Shaping the Medicine of the Future
Healthcare Trends 2020: How the UK is Shaping the Medicine of the FutureHealthcare Trends 2020: How the UK is Shaping the Medicine of the Future
Healthcare Trends 2020: How the UK is Shaping the Medicine of the Future
 

Mehr von igorod

Клаудмак
КлаудмакКлаудмак
Клаудмакigorod
 
Базелевс Инновации
Базелевс ИнновацииБазелевс Инновации
Базелевс Инновацииigorod
 
Сателлит Инновация
Сателлит ИнновацияСателлит Инновация
Сателлит Инновацияigorod
 
М-Пауэр Ворлд
М-Пауэр ВорлдМ-Пауэр Ворлд
М-Пауэр Ворлдigorod
 
ДАТАДВАНС
ДАТАДВАНСДАТАДВАНС
ДАТАДВАНСigorod
 
Фарма Био
Фарма БиоФарма Био
Фарма Биоigorod
 
Уральский центр биофармацевтических технологий
Уральский центр биофармацевтических технологийУральский центр биофармацевтических технологий
Уральский центр биофармацевтических технологийigorod
 
НьюВак
НьюВакНьюВак
НьюВакigorod
 
Команда энергичных предпринимателей
Команда энергичных предпринимателейКоманда энергичных предпринимателей
Команда энергичных предпринимателейigorod
 
АБИ ИнфоПоиск
АБИ ИнфоПоискАБИ ИнфоПоиск
АБИ ИнфоПоискigorod
 
Инноград Пущино
Инноград ПущиноИнноград Пущино
Инноград Пущиноigorod
 
Технопарк «Сколково»
Технопарк «Сколково»Технопарк «Сколково»
Технопарк «Сколково»igorod
 
Научно-технический Центр тонкопленочных технологий на основе кремния
Научно-технический Центр тонкопленочных технологий на основе кремнияНаучно-технический Центр тонкопленочных технологий на основе кремния
Научно-технический Центр тонкопленочных технологий на основе кремнияigorod
 
CeBIT: Благодарственное письмо В.Ф.Вексельбергу (немецкий)
CeBIT: Благодарственное письмо В.Ф.Вексельбергу (немецкий)CeBIT: Благодарственное письмо В.Ф.Вексельбергу (немецкий)
CeBIT: Благодарственное письмо В.Ф.Вексельбергу (немецкий)igorod
 
CeBIT: Благодарственное письмо В.Ф.Вексельбергу
CeBIT: Благодарственное письмо В.Ф.ВексельбергуCeBIT: Благодарственное письмо В.Ф.Вексельбергу
CeBIT: Благодарственное письмо В.Ф.Вексельбергуigorod
 
Меморандум о сотрудничестве между Торговым представительством Российской Феде...
Меморандум о сотрудничестве между Торговым представительством Российской Феде...Меморандум о сотрудничестве между Торговым представительством Российской Феде...
Меморандум о сотрудничестве между Торговым представительством Российской Феде...igorod
 
Технопарк «Сколково»
Технопарк «Сколково»Технопарк «Сколково»
Технопарк «Сколково»igorod
 
Кластер биологических и медицинских технологий: Проекты
Кластер биологических и медицинских технологий: ПроектыКластер биологических и медицинских технологий: Проекты
Кластер биологических и медицинских технологий: Проектыigorod
 
Определение приоритетных направлений развития (форсайт) кластера Энергоэффект...
Определение приоритетных направлений развития (форсайт) кластера Энергоэффект...Определение приоритетных направлений развития (форсайт) кластера Энергоэффект...
Определение приоритетных направлений развития (форсайт) кластера Энергоэффект...igorod
 
CeBIT Благодарственное письмо В.Ф. Вексельбергу
CeBIT Благодарственное письмо В.Ф. ВексельбергуCeBIT Благодарственное письмо В.Ф. Вексельбергу
CeBIT Благодарственное письмо В.Ф. Вексельбергуigorod
 

Mehr von igorod (20)

Клаудмак
КлаудмакКлаудмак
Клаудмак
 
Базелевс Инновации
Базелевс ИнновацииБазелевс Инновации
Базелевс Инновации
 
Сателлит Инновация
Сателлит ИнновацияСателлит Инновация
Сателлит Инновация
 
М-Пауэр Ворлд
М-Пауэр ВорлдМ-Пауэр Ворлд
М-Пауэр Ворлд
 
ДАТАДВАНС
ДАТАДВАНСДАТАДВАНС
ДАТАДВАНС
 
Фарма Био
Фарма БиоФарма Био
Фарма Био
 
Уральский центр биофармацевтических технологий
Уральский центр биофармацевтических технологийУральский центр биофармацевтических технологий
Уральский центр биофармацевтических технологий
 
НьюВак
НьюВакНьюВак
НьюВак
 
Команда энергичных предпринимателей
Команда энергичных предпринимателейКоманда энергичных предпринимателей
Команда энергичных предпринимателей
 
АБИ ИнфоПоиск
АБИ ИнфоПоискАБИ ИнфоПоиск
АБИ ИнфоПоиск
 
Инноград Пущино
Инноград ПущиноИнноград Пущино
Инноград Пущино
 
Технопарк «Сколково»
Технопарк «Сколково»Технопарк «Сколково»
Технопарк «Сколково»
 
Научно-технический Центр тонкопленочных технологий на основе кремния
Научно-технический Центр тонкопленочных технологий на основе кремнияНаучно-технический Центр тонкопленочных технологий на основе кремния
Научно-технический Центр тонкопленочных технологий на основе кремния
 
CeBIT: Благодарственное письмо В.Ф.Вексельбергу (немецкий)
CeBIT: Благодарственное письмо В.Ф.Вексельбергу (немецкий)CeBIT: Благодарственное письмо В.Ф.Вексельбергу (немецкий)
CeBIT: Благодарственное письмо В.Ф.Вексельбергу (немецкий)
 
CeBIT: Благодарственное письмо В.Ф.Вексельбергу
CeBIT: Благодарственное письмо В.Ф.ВексельбергуCeBIT: Благодарственное письмо В.Ф.Вексельбергу
CeBIT: Благодарственное письмо В.Ф.Вексельбергу
 
Меморандум о сотрудничестве между Торговым представительством Российской Феде...
Меморандум о сотрудничестве между Торговым представительством Российской Феде...Меморандум о сотрудничестве между Торговым представительством Российской Феде...
Меморандум о сотрудничестве между Торговым представительством Российской Феде...
 
Технопарк «Сколково»
Технопарк «Сколково»Технопарк «Сколково»
Технопарк «Сколково»
 
Кластер биологических и медицинских технологий: Проекты
Кластер биологических и медицинских технологий: ПроектыКластер биологических и медицинских технологий: Проекты
Кластер биологических и медицинских технологий: Проекты
 
Определение приоритетных направлений развития (форсайт) кластера Энергоэффект...
Определение приоритетных направлений развития (форсайт) кластера Энергоэффект...Определение приоритетных направлений развития (форсайт) кластера Энергоэффект...
Определение приоритетных направлений развития (форсайт) кластера Энергоэффект...
 
CeBIT Благодарственное письмо В.Ф. Вексельбергу
CeBIT Благодарственное письмо В.Ф. ВексельбергуCeBIT Благодарственное письмо В.Ф. Вексельбергу
CeBIT Благодарственное письмо В.Ф. Вексельбергу
 

Detlev Ganten Skolkovo biomedical technologies opportunities and challenges

  • 1. U N I V E R S I T Ä T S M E D I Z I N B E R L I N Prof. Dr. Detlev Ganten, February 2, 2011 [email_address] BioMedical technologies at Skolkovo: Opportunities and Challenges.
  • 2.
  • 3.  
  • 4. Science for Higher Education 19. November 2010 R&D expenditure in billions of Euro (2007 data) Source: BUFI 2010 EN
  • 5.
  • 6. Awards per scientific discipline per funding line 1st round Science for Higher Education 19. November 2010 Source: DFG 2010
  • 7.
  • 8.  
  • 9. 300 Mio 300 Mio 100 Mio about 2 billion people are treated according to scientific standards. about 5 billion people are badly treated or not taken care of at all. 100 Mio
  • 10. Evolutionary Medicine: our biologigal history goes back to the origins of life and works on old patents
  • 11.
  • 12.
  • 13. 1 Compound Annual Growth Rate (CAGR) Inpatient care SOURCE: OECD 4.0 17.5 2.2 3.2 6.1 10.9 3.2 25.3 3.8 3.0 4.4 2 8 8 10 10 13 14 34 51 80 Ancillary services Day care Primary prevention Investments in medical facilities Pharmaceutical goods Outpatient care Therapeutic appliances Home health care Health administra-tion and insurance Total health care expenditure Health care spend EUR billions, 2006 Annual growth rate* Percent, 1970 - 2006 In Germany, patient care and pharmaceuticals are among the biggest health care expenditures Expenditures for primary care have been growing slower than all other expenditures Total = 230 bn.
  • 14.
  • 15. Genotype Personalised Medizine Clinical Systems Biology Bioinformatics Sequencing, Analysis Phenotype Health – Disease Cardiovascular - Neuro - Cancer micro RNA, RNAi Drugs Biologicals aaa DNA (Genome: 20.000 Genes) RNA Proteins (Proteome) Metabolites (Metabolome) Cellular Biology Organs ( Microbiome)
  • 16. eMonitoring -Networking Sensors Analysis ? TeleMedicine – IT - for your personal Health Blut- zucker Blutdruck EKG Ther- mome- ter
  • 17. Telemedical Center of the Charit é – Global Service Med. Service LH nein Cardiology Traumatology Internal Medicine Toxicol. & others … Anesthesia/Ints. Care Ships, Yachts, Oil Plat. Home Care Private Flights Telemedical Call Center Emergency Unit Charité Foreign Hospitals: Moscow, Shanghai Ger. Foreign Office, Ger. Embassies Intern. Companies
  • 18. Architecture of the PfH- communication system Winkler S, Koehler F. Int J Cardiol 2010; in review. Patient Medical Partners TMC-physician Ambulance Hospital phys. GP Cardiologist Electronic Patient File Transmission paths for health data Transmission Transmission via Bluetooth Blood pressure ECG + SpO 2 Aktivity Weight Transmission via mobile phone Notification Treatmemt Control Communication paths in normal cases Communication paths in case of emergency Home emergency call IMMEDIATE REACTION Notification
  • 19. Telemedicine helps you to feel safe, even when you are on a lonely trip to Siberia All the best to you and your family.
  • 20. Berlin-Buch Adlershof BOSCH HU & FU GHC Global Health Care
  • 21.
  • 22.
  • 23.
  • 24. 300 Mio 300 Mio 100 Mio about 2 billion people are treated according to scientific standards. about 5 billion people are badly treated or not taken care of at all. 100 Mio
  • 25.  
  • 26.  
  • 27. The G 8 GROUP - G 20
  • 28. 1 Dec Nov Oct Sep Aug Jul Jun May Apr Mar Feb Jan World Health Summit serves as an annual conference of the M8
  • 29. U N I V E R S I T Ä T S M E D I Z I N B E R L I N Prof. Dr. Detlev Ganten , February 2, 2011 [email_address] BioMedical technologies at Skolkovo: Opportunities and Challenges. THANK YOU !